ARCHIVES

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

This article is from The Cancer Letter archive.

Vol. 35 No. 28 | July 17, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Anderson Assumes ACCC President, Enck President Elect; Reagan Reappoints Montgomery

April 11, 1986

Rituximab Maintenance Improves Survival In Relapse

February 27, 2009

Conte To Introduce Bill To Stem Loss Of NIH “Superstars”

March 31, 1989

Nixon National Cancer Conference Kicks Off

December 8, 2021

NCI Programs: Four Awarded Grants For Chem-Bio Centers; NCI To Commit $20M For Cancer Informatics Infrastructure

October 23, 1998

Trials Approved In October

December 28, 2001